2016-06-03
Exploring New Ways to Improve Treatment Outcome of Colorectal Liver Metastases
Publication
Publication
Verkennen van nieuwe manieren om resultaten van behandeling van colorectale levermetastasen te verbeteren
Chemotherapeutic agents are part of the multimodality approach for treatment in patients with CRLM. The associated toxicity is major limitation to their use, and leads to early discontinuation of treatment. Therefore, the aim of the studies described in this thesis was to describe two experimental subjects to ameliorate chemotherapeutic treatment in the multi-modality approach of colorectal liver metastases: the impact on the circadian clock and dietary restriction.
| Additional Metadata | |
|---|---|
| , , | |
| The research described in this thesis was funded by a grant from the Dutch Cancer Society (EMCR 2009-4506) The printing of this thesis has been financially supported by: Erasmus MC afdeling Heelkunde, Erasmus Universiteit Rotterdam, Franciscus Ziekenhuis Rotterdam, Pfizer, Rob en Karin Plas, Amgen, ChipSoft, Olympus Nederland BV, Erbe, Frits en Kitty Koopman, Herbers & Jenniskens Juweliers, Simendo BV | |
| J.N.M. IJzermans (Jan) , R.W.F. de Bruin (Ron) | |
| Erasmus University Rotterdam | |
| hdl.handle.net/1765/80253 | |
| Organisation | Erasmus MC: University Medical Center Rotterdam |
|
Huisman, S. (2016, June 3). Exploring New Ways to Improve Treatment Outcome of Colorectal Liver Metastases. Retrieved from http://hdl.handle.net/1765/80253 |
|
